2012 BIO International Convention Business Forum Looks to Host Record Breaking Number of Partnering Meetings
WASHINGTON, DC – (March 27, 2012) – With seven FDA drug approvals this year alone and investor optimism continuing to increase, the BIO Business Forum™ anticipates a record breaking number of partnering meetings at the 2012 BIO International Convention. The Biotechnology Industry Organization(BIO) announces the One-on-One Partnering™ System will open in early April. Hosted by BIO, this year’s global event for biotechnology will take place June 18-21, 2012 at the Boston Convention and Exhibition Center in Boston, MA.
“The BIO Business Forum™ is the industry’s largest partnering event. It provides an opportunity for senior business development executives, company management, service providers and select investorsto gather and discuss future collaborations and partnerships,” said BIO’sCEO and President Jim Greenwood. “These partnering meetings allow important business decisions to be made which are often times critical to the advancement of our industry.”
The BIO Business Forum™ has grown over the past eleven years to become the industry's largest partnering event, hosting a record breaking 21,000+ partnering meetings in 2011. Powered by BIO's One-on-One Partnering™ System, the BIO Business Forum™ fosters the opportunity for companies to initiate business contacts in a friendly environment and schedule meetings prior to the conference. To take advantage of partnering, please visit here.
New to the 2012 BIO International Convention and BIO Business Forum™, Exhibitor Partnering will allow qualified exhibitors to hold meetings in their personal exhibitor booths. Attendees will still have the opportunity to attend traditional partnering meetings, held in the Business Forum’s private meeting booths. To learn more about this exciting new addition, please visit here.
The BIO Business Forum™ also hosts company presentations which allow organizations to increase visibility, attract more partners and pitch their company objectives to a global audience representing over sixty countries and business development executives from both pharmaceutical and biotech companies.
The BIO International Convention will highlight the latest trends and the newest opportunities for executives, investors, scientists, policy leaders, and media from around the world. Speakers at the sessions will share breakthroughs in medicine, diagnostics, the environment, energy production, business operations, financing, partnerships, policy issues and food and agriculture. The Convention also features the BIO Business Forum™, a unique platform for biotechnology and pharmaceutical companies, academic research institutions, and investors from around the world to gather and discuss strategic opportunities. For registration, conference agenda and exhibitor information, visit 2012 BIO International Convention.